Advancing clinical and translational science to develop new therapies and treatments and improve health care

Become a Member

NJ ACTS is dedicated to leading the development of new approaches to the health problems of New Jersey and to translating those advances into therapies and treatments.

Find a Clinical Trial

Rutgers supports nearly 350 clinical trials at any given time. Our Rutgers Clinical Research Organization is the gateway to our statewide clinical trial activities

Funding Opportunities

NJ ACTS disseminates information on funding opportunities to its members and partner institutions, directly through emails and our website.

EVENTS


NEWS


Putting A Price On COVID-19 Treatment Remdesivir

Putting A Price On COVID-19 Treatment Remdesivir

Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That's when most drugs get price tags.  Gilead Sciences, which makes remdesivir, is...

HIGHLIGHTS